All Stories

  1. Clinical and Serological Biomarkers of Treatment’s Response in Multiple Sclerosis Patients Treated Continuously with Interferonβ-1b for More than a Decade

    Article • CNS & Neurological Disorders - Drug Targets, November 2018, Bentham Science Publishers

    Dr Smaranda Maria Maier, Zoltán Bajko , Adina Hutanu, Rodica Balasa

  2. Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action

    Article • CNS & Neurological Disorders - Drug Targets, January 2018, Bentham Science Publishers

    Dr Smaranda Maria Maier, Adina Hutanu, Rodica Balasa, Mihaela Adriana Simu, Zoltán Bajko

  3. Editorial. The Eleventh Hour: Neurosyphilis, Still Fashionable but a Controversial Diagnosis

    Article • The Journal of Critical Care Medicine, January 2017, De Gruyter

    Rodica Balasa

  4. Correlations between depression, cognitive status, functional scores, disability and lesion load in multiple sclerosis treated with interferon beta 1a

    Article • Acta Medica Marisiensis, January 2015, De Gruyter

    Rodica Balasa

  5. Acute ischaemic stroke secondary to a mobile thrombus in the common carotid artery - case report

    Article • The Journal of Critical Care Medicine, January 2015, De Gruyter

    Rodica Balasa